Wave Life Sciences Stock Today
| WVE Stock | USD 10.81 0.01 0.09% |
PerformanceVery Weak
| Odds Of DistressLow
|
Wave Life is trading at 10.81 as of the 17th of February 2025, a 0.09 percent increase since the beginning of the trading day. The stock's lowest day price was 10.64. Wave Life has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 18th of January 2025 and ending today, the 17th of February 2025. Click here to learn more.
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. The company was incorporated in 2012 and is based in Singapore. The company has 152.52 M outstanding shares of which 9.4 M shares are at this time shorted by investors with about 10.54 days to cover. More on Wave Life Sciences
Moving against Wave Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Wave Stock Highlights
| CEO President | MD MBA |
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, NASDAQ Composite, NASDAQ Health Care, Health Care, Pharmaceuticals, Biotechnology, Healthcare (View all Sectors) |
| Financial Strength | |
Wave Life Sciences (WVE) is traded on NASDAQ Exchange in USA. It is located in Marina One East Tower, Singapore, Singapore, 018936 and employs 266 people. Wave Life is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a total capitalization of 1.65 B. Wave Life Sciences runs under Pharmaceuticals sector within Health Care industry. The entity has 152.52 M outstanding shares of which 9.4 M shares are at this time shorted by investors with about 10.54 days to cover.
Wave Life Sciences has about 148.16 M in cash with (19.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.71.
Check Wave Life Probability Of Bankruptcy
Ownership AllocationThe majority of Wave Life outstanding shares are owned by institutional investors. These institutions are usually referred to as non-private investors looking to purchase positions in Wave Life Sciences to benefit from reduced commissions. Consequently, other corporate entities are subject to a different set of regulations than regular investors in Wave Life Sciences. Please pay attention to any change in the institutional holdings of Wave Life Sciences as this could imply that something significant has changed or is about to change at the company.
Check Wave Ownership Details
Wave Life Sciences Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Wave Life market risk premium is the additional return an investor will receive from holding Wave Life long position in a well-diversified portfolio.
| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.39) | |||
| Total Risk Alpha | (0.40) | |||
| Treynor Ratio | (1.08) |
Wave Stock Against Markets
Wave Life Corporate Management
| Kate Rausch | Investor Relations | Profile | |
| Stephen Lake | VP Devel | Profile | |
| Linda JD | Senior Counsel | Profile | |
| Erik MD | Chief Officer | Profile | |
| Sridhar Vaddeboina | Manufacturing Chemistry | Profile | |
| MBA MD | CEO Pres | Profile | |
| HsiuChiung Yang | Senior Medicine | Profile |
Already Invested in Wave Life Sciences?
The danger of trading Wave Life Sciences is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Wave Life is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Wave Life. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Wave Life Sciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Wave Life Sciences is a strong investment it is important to analyze Wave Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Wave Life's future performance. For an informed investment choice regarding Wave Stock, refer to the following important reports: Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Wave Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Wave Life. If investors know Wave will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Wave Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Wave Life Sciences is measured differently than its book value, which is the value of Wave that is recorded on the company's balance sheet. Investors also form their own opinion of Wave Life's value that differs from its market value or its book value, called intrinsic value, which is Wave Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Wave Life's market value can be influenced by many factors that don't directly affect Wave Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Wave Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Wave Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Wave Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.